Lupin inks pact with China's Sino Universal Pharmaceuticals for Tiotropium dry powder inhaler

Lupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler treats Chronic Obstructive Pulmonary Disease. Sino Universal will seek regulatory approvals. Lupin will manufacture the product. This collaboration expands Lupin's presence in China. It aims to improve respiratory disease treatment. The partnership focuses on providing high-quality healthcare solutions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zq8uATM
via IFTTT